Matches in Wikidata for { <http://www.wikidata.org/entity/Q57752107> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q57752107 description "article" @default.
- Q57752107 description "im Jahr 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57752107 description "wetenschappelijk artikel" @default.
- Q57752107 description "наукова стаття, опублікована у 2008" @default.
- Q57752107 name "Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial" @default.
- Q57752107 name "Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial" @default.
- Q57752107 type Item @default.
- Q57752107 label "Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial" @default.
- Q57752107 label "Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial" @default.
- Q57752107 prefLabel "Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial" @default.
- Q57752107 prefLabel "Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial" @default.
- Q57752107 P1433 Q57752107-30B87E2C-7170-4A70-BAEB-C9B513AE3BE0 @default.
- Q57752107 P1476 Q57752107-83FEBD62-BE6C-4F05-8017-7CDC6577D940 @default.
- Q57752107 P2093 Q57752107-26403A42-0470-495B-B3A3-14AE4B7CBD14 @default.
- Q57752107 P2093 Q57752107-3DFE5FF1-A44D-4EBB-A00E-79BF19C9B450 @default.
- Q57752107 P2093 Q57752107-3FEAEC94-A603-4E8B-9D2B-683F26AF902E @default.
- Q57752107 P2093 Q57752107-44D07EA4-D338-48F3-A292-6206B904930B @default.
- Q57752107 P2093 Q57752107-64F1235D-C066-4658-A013-15824DA75220 @default.
- Q57752107 P2093 Q57752107-AE4A294E-0638-48FC-BDD0-C2C7F35205D4 @default.
- Q57752107 P2093 Q57752107-FB23572E-640C-4D62-A8FD-63CCCE6329A2 @default.
- Q57752107 P2093 Q57752107-FB770D52-87FA-4634-A39D-6F220FFBF451 @default.
- Q57752107 P2860 Q57752107-6743E013-5774-4C98-9BCB-498855756375 @default.
- Q57752107 P2860 Q57752107-A44EEB73-F017-401A-B21F-F4FA637944C7 @default.
- Q57752107 P304 Q57752107-947E3063-7BF0-44BF-AD7C-D879912A0839 @default.
- Q57752107 P31 Q57752107-19DAE01D-577E-443D-A39A-7856B7B7D86A @default.
- Q57752107 P356 Q57752107-DB952F75-EBAB-4003-8811-219AC0B7C2F1 @default.
- Q57752107 P433 Q57752107-A2E8B64E-27F8-4B5E-B729-F33C3AA893F2 @default.
- Q57752107 P478 Q57752107-193FCB43-758F-4AC6-B961-D219FCBE3A78 @default.
- Q57752107 P50 Q57752107-58710E6F-90F1-486D-A3B9-8214EEBA9E5F @default.
- Q57752107 P50 Q57752107-A3969A3A-4CE3-45B2-8854-38C7C843D5C8 @default.
- Q57752107 P577 Q57752107-10732340-9AB8-44A0-B606-04F707CEFEF7 @default.
- Q57752107 P698 Q57752107-7B102C9F-1963-4D9D-9B79-8368C45F929D @default.
- Q57752107 P921 Q57752107-4BF0FC75-7E92-4713-B86E-59D5EEF80455 @default.
- Q57752107 P921 Q57752107-628D8110-4F04-4560-B704-37463AA41C15 @default.
- Q57752107 P921 Q57752107-77DFF893-82F9-4816-AF21-D8E18011E262 @default.
- Q57752107 P921 Q57752107-ADB0415F-83C0-47C4-B2B8-2E87EBDFCC4F @default.
- Q57752107 P921 Q57752107-D1925994-48C1-4C3C-A86D-04AB7B465936 @default.
- Q57752107 P921 Q57752107-F2186A70-739D-48F2-BAFA-F485D8C8913C @default.
- Q57752107 P356 ART.23417 @default.
- Q57752107 P698 18438830 @default.
- Q57752107 P1433 Q23929027 @default.
- Q57752107 P1476 "Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial" @default.
- Q57752107 P2093 "Charles G. Peterfy" @default.
- Q57752107 P2093 "John T. Sharp" @default.
- Q57752107 P2093 "Lifen Zhou" @default.
- Q57752107 P2093 "Nancy E. Lane" @default.
- Q57752107 P2093 "Peter A. Ory" @default.
- Q57752107 P2093 "Richard Newmark" @default.
- Q57752107 P2093 "Robin K. Dore" @default.
- Q57752107 P2093 "Wayne Tsuji" @default.
- Q57752107 P2860 Q35789185 @default.
- Q57752107 P2860 Q41753607 @default.
- Q57752107 P304 "1299-1309" @default.
- Q57752107 P31 Q13442814 @default.
- Q57752107 P356 "10.1002/ART.23417" @default.
- Q57752107 P433 "5" @default.
- Q57752107 P478 "58" @default.
- Q57752107 P50 Q47262835 @default.
- Q57752107 P50 Q91720749 @default.
- Q57752107 P577 "2008-01-01T00:00:00Z" @default.
- Q57752107 P698 "18438830" @default.
- Q57752107 P921 Q101929 @default.
- Q57752107 P921 Q187255 @default.
- Q57752107 P921 Q269829 @default.
- Q57752107 P921 Q327657 @default.
- Q57752107 P921 Q42824440 @default.
- Q57752107 P921 Q6934595 @default.